Since the early 1970s, Dr. Peter Breggin has been active as a medical expert in malpractice and product liability suits, as well as criminal cases in which psychiatric or psychoactive drugs have contributed to abnormal behavior. He has also testified in cases involving involuntary treatment, electroshock treatment, and psychosurgery. He has testified more than 70 times in court.

In the 1990s, Dr. Breggin was chosen to be the medical and scientific expert for nearly 200 combined Prozac product liability suits against Eli Lilly and Company. This resulted in his testifying in the infamous Wesbecker case in which the manufacturer, Eli Lilly, fixed the trial. Link. Later Dr. Breggin would become an expert in many other product liability suits involving antidepressants, stimulants, tranquilizers and antipsychotic drugs, nearly all of which were settled. As an expert in these product liability suits, the courts have empowered Dr. Breggin to examine secret company records concerning the development and marketing of their drugs. This unique experience of looking inside otherwise hidden drug company files has provided him a unique source of information and a special understanding of drug company activities that he has used in his legal work and documented in many publications, including Brain-Disabling Treatments in Psychiatry (2008) and Medication Madness (2008).

Among his proudest achievements, in the early 1970s Dr. Breggin was the medical expert in the famous Kaimowitz case that stopped lobotomy and psychosurgery in America’s state mental hospitals. LINK More recently he was the psychiatric expert in a psychosurgery case against the Cleveland Clinic that resulted in a huge verdict for the injured woman and caused the clinic to stop doing any further psychosurgery. LINK Dr. Breggin was also the medical expert in the only electroshock malpractice suit to be won by the plaintiffs. LINK.

Some of Dr. Breggin’s most successful legal work has involved testimony in tardive dyskinesia malpractice suits involving this usually irreversible abnormal movement disorder commonly caused by antipsychotic or neuroleptic drugs. In all but one of the many TD trials in which he has participated in the United States and Canada, the injured patient has won a favorable verdict. The one exception ended in a hung jury. He has also been involved in tardive dyskinesia cases with multi-million dollar settlements without going to trial in both the United States and Canada.

Dr. Breggin continues with both his clinical practice and his medical expert work.

Brief in Paxil withdrawal suit

Paxil Lawsuit Filed in California   The following suit has been brought in the State of California as a result of Dr. Peter Breggin’s work with attorney Don Farber  in association with the law offices of Vince D. Nguyen.  The suit is brought on behalf of the citizens of California and provides a model for […]

Read More

Paxil Withdrawal Case Settled in California

Paxil Withdrawal Case Settled in California A California lawsuit against Glaxo SmithKline (GSK) charged the drug company with failing to warn the public about the dangers of Paxil withdrawal.  Glaxo SmithKline (GSK), the manufacturer of the antidepressant Paxil, resolved the suit in January 2002.  The results of the resolution, including any settlement by defendant Glaxo […]

Read More

Judges Reduce Sentences in Latest Paxil and Prozac Criminal Cases

January, 2002 In two recent criminal cases, judges have reduced the sentences for violent crimes committed under influence of antidepressants.  In each case, the judges responded to expert testimony by psychiatrist Peter R. Breggin, M.D. concerning the adverse mental and behavior effects of SSRI antidepressants, specifically Prozac and Paxil.  Both judges concluded that the medications […]

Read More

Paxil Product Liability Suit Resolved

Paxil Product Liability Suit Resolved   A man with no previous history of violence or suicide drowned himself and his two children in a bathtub after taking two doses of Paxil.  Paxil is an antidepressant of the SSRI (selective serotonin reuptake inhibitor) class that also includes Prozac, Zoloft, Celexa and Luvox.  Psychiatrist Peter R. Breggin, […]

Read More

Mood-altering verdict: Prozac Case

Reprinted with permission from: ABA JOURNAL August, 1996, page 18 Mood-altering Verdict Judge suspects Prozac settlement though case went to jury BY JOHN GIBEAUT   Circuit Judge John W. Potter couldn’t shake his suspicion that the parties had secretly settled a case involving the antidepressant Prozac — and let him send it to the jury […]

Read More

Menninger Clinic Case

Patient Dies in Clinical Drug Trial: Menninger Clinic Found Negligent by Jury In mid-December 2001, a jury found the Menninger Clinic (then of Topeka, KS, now relocated to Houston, TX)  negligent in the treatment of an individual who was placed in a clinical trial in which he received an experimental neuroleptic (antipsychotic drug).  Psychiatrist Peter […]

Read More

Violence and Suicide Caused by Antidepressants Report to the FDA

by Peter R. Breggin, M.D. August 23, 2004 On March 22, 2004 the FDA issued a “Public Health Advisory” cautioning about the risks associated with the new generation of antidepressants including the SSRIs. In examining drug-induced suicide, the FDA’s also observed that certain behaviors are “known to be associated with these drugs,” including “anxiety, agitation, […]

Read More

TD case settled after Breggin testimony

A tardive dyskinesia malpractice case was settled in trial following testimony by psychiatrist Peter R. Breggin, M.D. on behalf of the plaintiff in November 2001.  The settlement amount was not disclosed but was considered more than satisfactory by the plaintiff.  Dr. Breggin was the plaintiff’s only expert.  Dr. Breggin has a longstanding concern about tardive […]

Read More